Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
8.42
-0.23 (-2.60%)
Mar 31, 2025, 9:47 AM EDT - Market open
Neogen Revenue
Neogen had revenue of $231.26M in the quarter ending November 30, 2024, with 0.71% growth. This brings the company's revenue in the last twelve months to $913.83M, down -0.53% year-over-year. In the fiscal year ending May 31, 2024, Neogen had annual revenue of $924.22M with 12.37% growth.
Revenue (ttm)
$913.83M
Revenue Growth
-0.53%
P/S Ratio
2.05
Revenue / Employee
$313,277
Employees
2,917
Market Cap
1.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 924.22M | 101.78M | 12.37% |
May 31, 2023 | 822.45M | 295.29M | 56.01% |
May 31, 2022 | 527.16M | 58.70M | 12.53% |
May 31, 2021 | 468.46M | 50.29M | 12.03% |
May 31, 2020 | 418.17M | 3.98M | 0.96% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
NEOG News
- 10 days ago - Neogen Announces Third-Quarter Earnings Release Date - PRNewsWire
- 5 weeks ago - NLRB Withdraws Unfair Labor Practices Claim Against Neogen® - PRNewsWire
- 2 months ago - Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors - Seeking Alpha
- 2 months ago - Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk - PRNewsWire
- 2 months ago - Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay - PRNewsWire
- 2 months ago - Neogen Corporation (NEOG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Neogen Announces Preliminary¹ Second-Quarter 2025 Results - PRNewsWire
- 2 months ago - Neogen® To Participate in Upcoming Investor Conferences - PRNewsWire